Institutional investors purchased a net $1.4 million shares of OPK during the quarter ended March 2017. This may signal that the smart money is gaining interest in this company as the 24.10% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SSGA FUNDS MANAGEMENT, INC. Bought 3.1 Million shares of OPKO Health Inc
AMITIM SENIOR PENSION FUNDS Bought 1.9 Million shares of OPKO Health Inc
THE VANGUARD GROUP, INC. Bought 1.1 Million shares of OPKO Health Inc